Open AccessWITHDRAWN: EGFR exon 19 deletion is associated with favorable overall survival after first-line icotinib therapy in advanced non-small cell lung cancer patients: a retrospective, multiple-center, real-world study
Author(s) -
Chuantao Zhang,
Helei Hou,
Xin Cheng,
Dian-xia Gong,
Yang Ling,
Haixin Liu,
Wenyong Zhu,
Na Zhou,
Yan Zhu,
Ling Chen,
Kewei Liu,
Jingjuan Zhu,
Hongying Lv,
Tianjun Li,
Dong Liu,
Jing Cong,
Man Jiang,
Yakun Zhang,
Hualong Yu,
Hongsheng Yu,
Xiaochun Zhang
Publication year - 2017
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.23720
Subject(s) - medicine , afatinib , lung cancer , erlotinib , china , oncology , targeted therapy , epidermal growth factor receptor , family medicine , cancer , political science , law
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom